Literature DB >> 21976446

Perfusion culture enhanced human endometrial stromal cell growth in alginate-multivalent integrin α5β1 ligand scaffolds.

Zhaohui Li1, Michaela Kreiner, RuAngelie Edrada-Ebel, Zhanfeng Cui, Christopher F van der Walle, Helen J Mardon.   

Abstract

A method to functionalize alginate by introducing monomeric or self-assembling (tetrameric) fibronectin (FN) domains is described, leading to a functional scaffold, which is used for three dimensional (3D) culture of human endometrial stromal cells (EnSCs). EnSCs encapsulated in the functional alginate were cultured under perfusion using the TissueFlex® platform, a multiple parallel microbioreactor system for 3D cell culture. The effect of the novel scaffold and the effect of perfusion were examined. Cell viability, proliferation, and extracellular matrix (ECM) deposition were determined and the results compared with those obtained with cells encapsulated in non-functionalized alginate, and also those without perfusion. Staining for focal adhesions and actin showed maximal cell adhesion only for alginate-tetrameric FN scaffolds under perfusion, associated with a significant increase in cell number over 7 days culture; in contrast to poor cell adhesion and a decrease in cell number for non-functionalized alginate scaffolds (irrespective of perfused/static culture) and 3D static culture (irrespective of the scaffold). Conjugation of alginate to FN was an absolute requirement to attenuate the loss of cell metabolic activity over 7 days culture. ECM deposition for blank alginate and alginate-monomeric FN was similar, but increased around 2-fold and 3-fold for alginate-tetrameric FN under static and perfusion culture, respectively. It is concluded that the requirement for EnSC engagement with multivalent integrin α5β1 ligands and perfused culture are both essential as a first step toward endometrial tissue engineering.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976446     DOI: 10.1002/jbm.a.33177

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

1.  Local remodeling of synthetic extracellular matrix microenvironments by co-cultured endometrial epithelial and stromal cells enables long-term dynamic physiological function.

Authors:  Christi D Cook; Abby S Hill; Margaret Guo; Linda Stockdale; Julia P Papps; Keith B Isaacson; Douglas A Lauffenburger; Linda G Griffith
Journal:  Integr Biol (Camb)       Date:  2017-04-18       Impact factor: 2.192

2.  Optimization and scale-up culture of human endometrial multipotent mesenchymal stromal cells: potential for clinical application.

Authors:  Gayathri Rajaraman; Jacinta White; Ker Sin Tan; Daniela Ulrich; Anna Rosamilia; Jerome Werkmeister; Caroline E Gargett
Journal:  Tissue Eng Part C Methods       Date:  2012-08-02       Impact factor: 3.056

3.  Interrogating protonated/deuterated fibronectin fragment layers adsorbed to titania by neutron reflectivity and their concomitant control over cell adhesion.

Authors:  Lisa McIntosh; Christine Whitelaw; Agata Rekas; Stephen A Holt; Christopher F van der Walle
Journal:  J R Soc Interface       Date:  2015-06-06       Impact factor: 4.118

Review 4.  Bioengineering of the Uterus.

Authors:  Yushi Yoshimasa; Tetsuo Maruyama
Journal:  Reprod Sci       Date:  2021-04-07       Impact factor: 3.060

5.  In vitro biomimetic platforms featuring a perfusion system and 3D spheroid culture promote the construction of tissue-engineered corneal endothelial layers.

Authors:  Shanyi Li; Yuting Han; Hao Lei; Yingxin Zeng; Zekai Cui; Qiaolang Zeng; Deliang Zhu; Ruiling Lian; Jun Zhang; Zhe Chen; Jiansu Chen
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

6.  Development of in vitro 3D TissueFlex® islet model for diabetic drug efficacy testing.

Authors:  Zhaohui Li; He Sun; Jianbin Zhang; Haijiao Zhang; Fanyu Meng; Zhanfeng Cui
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.